37,360 Shares in FibroBiologics, Inc. (NASDAQ:FBLG) Purchased by RMR Wealth Builders

RMR Wealth Builders purchased a new stake in FibroBiologics, Inc. (NASDAQ:FBLG) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 37,360 shares of the company’s stock, valued at approximately $186,000. RMR Wealth Builders owned 0.10% of FibroBiologics at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. Saxon Interests Inc. acquired a new position in FibroBiologics in the second quarter valued at about $106,000. ERn Financial LLC bought a new position in shares of FibroBiologics during the 2nd quarter valued at about $159,000. Finally, Transform Wealth LLC acquired a new position in shares of FibroBiologics in the 2nd quarter valued at approximately $668,000.

FibroBiologics Trading Down 11.1 %

FBLG traded down $0.18 during trading on Thursday, hitting $1.40. The company had a trading volume of 121,310 shares, compared to its average volume of 189,171. The firm’s 50-day moving average price is $4.32 and its 200 day moving average price is $8.55. FibroBiologics, Inc. has a one year low of $1.08 and a one year high of $55.00.

FibroBiologics Profile

FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. It holds 150+ U.S. and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer.